BioHarvest Sciences Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
BHST Nasdaq 2840 www.bioharvest.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioHarvest Sciences Inc.

BioHarvest Sciences Inc (BHST) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Nov 13th, 2025 10:04 pm
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates - Nov 13th, 2025 3:50 pm
BioHarvest Sciences Reports Third Quarter 2025 Financial Results - Nov 13th, 2025 2:05 pm
Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 3:25 pm
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025 - Nov 12th, 2025 6:42 am
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares - Nov 10th, 2025 2:18 pm
Compugen (CGEN) Reports Q3 Loss, Lags Revenue Estimates - Nov 10th, 2025 6:15 am
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock - Nov 7th, 2025 5:30 am
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates - Nov 6th, 2025 6:00 pm
BioHarvest Announces Proposed Public Offering of Common Stock - Nov 6th, 2025 2:37 pm
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time - Nov 4th, 2025 5:30 am
BioHarvest Sciences (BHST) Announces Strategic CDMO Agreement With Saffron Tech - Nov 3rd, 2025 7:37 pm
Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates - Nov 3rd, 2025 3:35 pm
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis - Oct 30th, 2025 5:30 am
3 Top Growth Stocks Insiders Are Eager To Hold - Oct 10th, 2025 11:35 am
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction - Sep 22nd, 2025 4:32 am
Are Investors Undervaluing BioHarvest Sciences Inc. (NASDAQ:BHST) By 49%? - Sep 11th, 2025 1:30 pm
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale - Sep 10th, 2025 5:00 am
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET - Sep 2nd, 2025 6:30 am
BioHarvest Sciences Second Quarter 2025 Earnings: EPS Misses Expectations - Aug 15th, 2025 1:07 pm